Tech Company Financing Transactions
Ginkgo Bioworks Funding Round
Ginkgo Bioworks, based in Boston, secured $70 million from General Atlantic, Illumina Ventures and Viking Global Investors.
Transaction Overview
Company Name
Announced On
6/1/2020
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to leverage Illumina's sequencing (NGS) technology to enable widespread testing for COVID-19.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
27 Drydock Ave. 8th Floor
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Ginkgo Bioworks is the organism company. We design custom microbes for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Kelly
Founder
Barry Canton
Founder
Austin Che
Founder
Thomas Knight
Founder
Reshma Shetty
Browse more venture capital transactions:
Prev: 6/1/2020: Orbita venture capital transaction
Next: 6/2/2020: Ezra venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs